News - UF Innovate

JAMA Neurology Publishes Landmark Study Showing Neuropacs™ AI Technology Significantly Enhances the Diagnostic Accuracy of Parkinson’s Disease and Atypical Parkinsonism

UF startup neuropacs™ Corp., a leading innovator in AI-driven neurological diagnostics, announces the results of a prospective multicenter study that evaluated neuropacs™ AI technology for diagnosing Parkinson’s disease and atypical parkinsonism.

Research Shows AI Technology Improves Parkinson’s Diagnoses

UF researchers have developed a new kind of software that will help clinicians differentially diagnose Parkinson’s disease and related conditions, reducing diagnostic time and increasing precision beyond 96%.

UF Professor To Expand Proven Disease-Prediction Dashboard To Monitor Gulf Threats

UF researcher Antar Jutla has deployed his Cholera Risk Dashboard in about 20 countries to monitor cholera bacteria using NASA and NOAA satellite images and artificial intelligence algorithms.

iOncologi, Inc. Acquires TargImmune Therapeutics To Expand and Strengthen Immunotherapy Pipeline Against Solid Tumors

UF startup iOncologi announced the acquisition of TargImmune Therapeutics to enhance its capabilities in developing immunotherapies for solid tumors.

UF Researchers Demonstrate GLP-1RAs’ Potential To Treat Depression

UF researchers have found that GLP-1RAs, a class of glucose-lowering medications, may have antidepressant effects in a study funded by the NIH.

Mutations Disrupt Touch-Based Learning, Study Finds

UF researchers, supported by the National Institutes of Health, have found that the Syngap1 gene plays a crucial role in touch-based perception, while certain mutations can lead to mixed signals.

UF Ranked Among World’s Top Universities in Number of Patents

The National Academy of Inventors ranked the University of Florida No. 20 on the list of Top 100 Worldwide Universities Granted Utility Patents in 2024.

University of Florida Studies Use of Eye Tracking Technology With Public Transit Drivers

In this week’s Tech Tuesday, UF Innovate's host Bethany Gaffey introduces Bryce Grame, a UF Ph.D. student, who, along with his team at the UF Transportation Institute, conducted a study using eye-tracking technology to enhance safety and training for transit drivers in public transportation.

Atsena Therapeutics Granted U.S. FDA Fast Track Designation for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis

UF startup Atsena Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ATSN-201 for the treatment of X-linked retinoschisis (XLRS).

UF News